Arena Pharmaceuticals, Inc. (ARNA) reported a second-quarter net loss allocable to common stockholders of $22.1 million or $0.12 per share, narrower than $22.9 million or $0.16 per share in the year-ago quarter.
Total revenue for the second quarter rose to $21.98 million from $3.26 million in the comparable quarter last year.
On average, analysts polled by Thomson Reuters expected the company report a loss of $0.07 per share on revenue of $10.04 million for the second quarter.
For comments and feedback: editorial@rttnews.com